SCHEMBL21532408

SCHEMBL21532408

c1ccc(-c2nnc(-c3ccccc3)n2-c2cccc3c4ccccc4n(-c4cccc(-c5cccc(-n6c7ccccc7c7c6ccc6c8ccccc8n(-c8ccccc8)c67)c5)c4)c23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
AVPR1A P37288 1/20 0.36
OPRD1 P41143 2/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
HIF1A Q16665 1/20 0.34
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34
KMT2A Q03164 1/20 0.34
ALDH1A1 P00352 2/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HPGD P15428 2/20 0.33
AKT1 P31749 1/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
RXFP1 Q9HBX9 1/20 0.32
JAK2 O60674 1/20 0.32
JAK3 P52333 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532719 0.97 KDM4E (0.40) KDM4EATML3MBTL1AVPR1AOPRD1
SCHEMBL21532581 0.96 KDM4E (0.39) KDM4EATML3MBTL1AVPR1AOPRD1
SCHEMBL23911752 0.95 KDM4E (0.37) KDM4EATML3MBTL1AVPR1AOPRD1
SCHEMBL21532734 0.92 KDM4E (0.40) KDM4EATML3MBTL1AVPR1AOPRD1
SCHEMBL21532415 0.92 KDM4E (0.39) KDM4EATML3MBTL1AVPR1AOPRD1
SCHEMBL24990389 0.91 L3MBTL1 (0.45) KDM4EATML3MBTL1MEN1GAA
SCHEMBL24990392 0.91 L3MBTL1 (0.45) KDM4EATML3MBTL1MEN1GAA
SCHEMBL21532398 0.90 KDM4E (0.40) KDM4EATML3MBTL1AVPR1AOPRD1
SCHEMBL21532401 0.90 KDM4E (0.40) KDM4EATML3MBTL1AVPR1AOPRD1
SCHEMBL21532399 0.90 KDM4E (0.40) KDM4EATML3MBTL1AVPR1AOPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same CRY1, CCNT1, CCNA1 KDM4E 4144/4885ATM 622/4885L3MBTL1 370/4885
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, ARL1 KDM4E 3893/4885ATM 368/4885L3MBTL1 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.